AUG 17, 2026 · PHASE 3 TRIAL
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ClinicalTrials.gov
This is a recruiting Phase 3 RCT registration with no reported results; the study design is sound but outcomes are not yet available, making it a planned trial rather than evidence of efficacy.
Reported
Planned enrollment404
Primary outcome measureOverall Survival
Follow-up durationUp to 60 months